Terminal vascular intervention refers to the use of 1-2 mm thick puncture needles to penetrate the shallow arteries and veins of the human body to enter the human vascular system. With the knowledge of vascular anatomy, the doctor will guide the catheter to the lesion under the guidance of the angiography machine. At this location, a method of injecting a contrast agent through a catheter, displaying the condition of the diseased blood vessel, and treating the disease in the blood vessel. Common body surface puncture points include femoral arteriovenous, radial arteries, subclavian arteriovenous, jugular vein arteriovenous, and so on.
Highlights
The global Terminal Vascular Intervention market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Terminal Vascular Intervention is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Terminal Vascular Intervention is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Terminal Vascular Intervention in Vascular Disease is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Terminal Vascular Intervention include Abbott Laboratories, AgioDynamics Inc., B. Braun, Cardinal Health, Biotronik, Boston Scientific Corporation, Cook Group, C.R. Bard and Depuy Synthesis, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Terminal Vascular Intervention, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terminal Vascular Intervention.
The Terminal Vascular Intervention market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Terminal Vascular Intervention market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terminal Vascular Intervention companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
AgioDynamics Inc.
B. Braun
Cardinal Health
Biotronik
Boston Scientific Corporation
Cook Group
C.R. Bard
Depuy Synthesis
Medtronic
Meril Life Sciences India Pvt Ltd
Teleflex
Segment by Type
Catheter Guide
Rotary Cutting Equipment
Embolization Equipment
Thrombectomy equipment
IVC Filter
Other
Segment by Application
Vascular Disease
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Terminal Vascular Intervention companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Terminal Vascular Intervention Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Catheter Guide
1.2.3 Rotary Cutting Equipment
1.2.4 Embolization Equipment
1.2.5 Thrombectomy equipment
1.2.6 IVC Filter
1.2.7 Other
1.3 Market by Application
1.3.1 Global Terminal Vascular Intervention Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Vascular Disease
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Terminal Vascular Intervention Market Perspective (2018-2029)
2.2 Terminal Vascular Intervention Growth Trends by Region
2.2.1 Global Terminal Vascular Intervention Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Terminal Vascular Intervention Historic Market Size by Region (2018-2023)
2.2.3 Terminal Vascular Intervention Forecasted Market Size by Region (2024-2029)
2.3 Terminal Vascular Intervention Market Dynamics
2.3.1 Terminal Vascular Intervention Industry Trends
2.3.2 Terminal Vascular Intervention Market Drivers
2.3.3 Terminal Vascular Intervention Market Challenges
2.3.4 Terminal Vascular Intervention Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Terminal Vascular Intervention Players by Revenue
3.1.1 Global Top Terminal Vascular Intervention Players by Revenue (2018-2023)
3.1.2 Global Terminal Vascular Intervention Revenue Market Share by Players (2018-2023)
3.2 Global Terminal Vascular Intervention Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Terminal Vascular Intervention Revenue
3.4 Global Terminal Vascular Intervention Market Concentration Ratio
3.4.1 Global Terminal Vascular Intervention Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Terminal Vascular Intervention Revenue in 2022
3.5 Terminal Vascular Intervention Key Players Head office and Area Served
3.6 Key Players Terminal Vascular Intervention Product Solution and Service
3.7 Date of Enter into Terminal Vascular Intervention Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Terminal Vascular Intervention Breakdown Data by Type
4.1 Global Terminal Vascular Intervention Historic Market Size by Type (2018-2023)
4.2 Global Terminal Vascular Intervention Forecasted Market Size by Type (2024-2029)
5 Terminal Vascular Intervention Breakdown Data by Application
5.1 Global Terminal Vascular Intervention Historic Market Size by Application (2018-2023)
5.2 Global Terminal Vascular Intervention Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Terminal Vascular Intervention Market Size (2018-2029)
6.2 North America Terminal Vascular Intervention Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Terminal Vascular Intervention Market Size by Country (2018-2023)
6.4 North America Terminal Vascular Intervention Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Terminal Vascular Intervention Market Size (2018-2029)
7.2 Europe Terminal Vascular Intervention Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Terminal Vascular Intervention Market Size by Country (2018-2023)
7.4 Europe Terminal Vascular Intervention Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Terminal Vascular Intervention Market Size (2018-2029)
8.2 Asia-Pacific Terminal Vascular Intervention Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Terminal Vascular Intervention Market Size by Region (2018-2023)
8.4 Asia-Pacific Terminal Vascular Intervention Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Terminal Vascular Intervention Market Size (2018-2029)
9.2 Latin America Terminal Vascular Intervention Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Terminal Vascular Intervention Market Size by Country (2018-2023)
9.4 Latin America Terminal Vascular Intervention Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Terminal Vascular Intervention Market Size (2018-2029)
10.2 Middle East & Africa Terminal Vascular Intervention Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Terminal Vascular Intervention Market Size by Country (2018-2023)
10.4 Middle East & Africa Terminal Vascular Intervention Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Terminal Vascular Intervention Introduction
11.1.4 Abbott Laboratories Revenue in Terminal Vascular Intervention Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 AgioDynamics Inc.
11.2.1 AgioDynamics Inc. Company Detail
11.2.2 AgioDynamics Inc. Business Overview
11.2.3 AgioDynamics Inc. Terminal Vascular Intervention Introduction
11.2.4 AgioDynamics Inc. Revenue in Terminal Vascular Intervention Business (2018-2023)
11.2.5 AgioDynamics Inc. Recent Development
11.3 B. Braun
11.3.1 B. Braun Company Detail
11.3.2 B. Braun Business Overview
11.3.3 B. Braun Terminal Vascular Intervention Introduction
11.3.4 B. Braun Revenue in Terminal Vascular Intervention Business (2018-2023)
11.3.5 B. Braun Recent Development
11.4 Cardinal Health
11.4.1 Cardinal Health Company Detail
11.4.2 Cardinal Health Business Overview
11.4.3 Cardinal Health Terminal Vascular Intervention Introduction
11.4.4 Cardinal Health Revenue in Terminal Vascular Intervention Business (2018-2023)
11.4.5 Cardinal Health Recent Development
11.5 Biotronik
11.5.1 Biotronik Company Detail
11.5.2 Biotronik Business Overview
11.5.3 Biotronik Terminal Vascular Intervention Introduction
11.5.4 Biotronik Revenue in Terminal Vascular Intervention Business (2018-2023)
11.5.5 Biotronik Recent Development
11.6 Boston Scientific Corporation
11.6.1 Boston Scientific Corporation Company Detail
11.6.2 Boston Scientific Corporation Business Overview
11.6.3 Boston Scientific Corporation Terminal Vascular Intervention Introduction
11.6.4 Boston Scientific Corporation Revenue in Terminal Vascular Intervention Business (2018-2023)
11.6.5 Boston Scientific Corporation Recent Development
11.7 Cook Group
11.7.1 Cook Group Company Detail
11.7.2 Cook Group Business Overview
11.7.3 Cook Group Terminal Vascular Intervention Introduction
11.7.4 Cook Group Revenue in Terminal Vascular Intervention Business (2018-2023)
11.7.5 Cook Group Recent Development
11.8 C.R. Bard
11.8.1 C.R. Bard Company Detail
11.8.2 C.R. Bard Business Overview
11.8.3 C.R. Bard Terminal Vascular Intervention Introduction
11.8.4 C.R. Bard Revenue in Terminal Vascular Intervention Business (2018-2023)
11.8.5 C.R. Bard Recent Development
11.9 Depuy Synthesis
11.9.1 Depuy Synthesis Company Detail
11.9.2 Depuy Synthesis Business Overview
11.9.3 Depuy Synthesis Terminal Vascular Intervention Introduction
11.9.4 Depuy Synthesis Revenue in Terminal Vascular Intervention Business (2018-2023)
11.9.5 Depuy Synthesis Recent Development
11.10 Medtronic
11.10.1 Medtronic Company Detail
11.10.2 Medtronic Business Overview
11.10.3 Medtronic Terminal Vascular Intervention Introduction
11.10.4 Medtronic Revenue in Terminal Vascular Intervention Business (2018-2023)
11.10.5 Medtronic Recent Development
11.11 Meril Life Sciences India Pvt Ltd
11.11.1 Meril Life Sciences India Pvt Ltd Company Detail
11.11.2 Meril Life Sciences India Pvt Ltd Business Overview
11.11.3 Meril Life Sciences India Pvt Ltd Terminal Vascular Intervention Introduction
11.11.4 Meril Life Sciences India Pvt Ltd Revenue in Terminal Vascular Intervention Business (2018-2023)
11.11.5 Meril Life Sciences India Pvt Ltd Recent Development
11.12 Teleflex
11.12.1 Teleflex Company Detail
11.12.2 Teleflex Business Overview
11.12.3 Teleflex Terminal Vascular Intervention Introduction
11.12.4 Teleflex Revenue in Terminal Vascular Intervention Business (2018-2023)
11.12.5 Teleflex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
AgioDynamics Inc.
B. Braun
Cardinal Health
Biotronik
Boston Scientific Corporation
Cook Group
C.R. Bard
Depuy Synthesis
Medtronic
Meril Life Sciences India Pvt Ltd
Teleflex
听
听
*If Applicable.
